Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism
- PMID: 16356429
- DOI: 10.1016/j.jpeds.2005.09.031
Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism
Abstract
Objectives: To evaluate the influence of initial and postinitial treatment factors on cognitive, psychomotor, and psychological outcome in schoolchildren with congenital hypothyroidism (CH).
Study design: We studied 45 patients (19 with severe CH and 26 with mild CH) and 37 control children by correlating initial and postinitial treatment factors (free thyroxine and thyroid-stimulating hormone [TSH] concentrations, and the percentage of overtreatment and undertreatment periods) with the results of neuropsychological tests and behavior (as reported on the Teacher Report Form [TRF]).
Results: The global IQ of the children with CH was comparable to that of the controls; visuomotor and verbal scores were lower, and total TRF scores were higher. Ethnic group, previous development, and overtreatment predicted IQ and verbal scores, with higher scores seen for the overtreated patients than for the control children and those patients who had not been overtreated. As initial treatment was less satisfactory, total TRF scores were higher.
Conclusions: Our study suggests that initial and postinitial suboptimal treatment of CH leads to abnormalities in IQ and specific fields. Overtreatment may advance cognitive development in 5-1/2- to 7-year-olds. Suboptimal initial treatment may lead to behavioral problems. We recommend that TSH concentrations be maintained within the normal range in patients with CH.
Similar articles
-
Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH.J Pediatr. 2005 Dec;147(6):775-80. doi: 10.1016/j.jpeds.2005.07.024. J Pediatr. 2005. PMID: 16356430 Clinical Trial.
-
Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism.J Pediatr. 2000 Mar;136(3):292-7. doi: 10.1067/mpd.2000.103351. J Pediatr. 2000. PMID: 10700683
-
Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine.J Pediatr. 2004 Jun;144(6):747-52. doi: 10.1016/j.jpeds.2004.02.021. J Pediatr. 2004. PMID: 15192621 Clinical Trial.
-
Pre- and postnatal brain development in neonates with congenital hypothyroidism.J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1463-8. J Pediatr Endocrinol Metab. 2001. PMID: 11837500 Review.
-
Update of newborn screening and therapy for congenital hypothyroidism.Pediatrics. 2006 Jun;117(6):2290-303. doi: 10.1542/peds.2006-0915. Pediatrics. 2006. PMID: 16740880 Review.
Cited by
-
Opposing Effects of Maternal Hypo- and Hyperthyroidism on the Stability of Thalamocortical Synapses in the Visual Cortex of Adult Offspring.Cereb Cortex. 2017 May 1;27(5):3015-3027. doi: 10.1093/cercor/bhw096. Cereb Cortex. 2017. PMID: 27235101 Free PMC article.
-
An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.Front Endocrinol (Lausanne). 2022 Jun 9;13:859487. doi: 10.3389/fendo.2022.859487. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757415 Free PMC article. Review.
-
Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks.Can Fam Physician. 2009 Dec;55(12):1184-92. Can Fam Physician. 2009. PMID: 20008595 Free PMC article. Review.
-
Congenital Hypothyroidism: Optimal Initial Dosage and Time of Initiation of Treatment: A Systematic Review.Int J Endocrinol Metab. 2016 Jun 14;14(3):e36080. doi: 10.5812/ijem.36080. eCollection 2016 Jul. Int J Endocrinol Metab. 2016. PMID: 27942261 Free PMC article. Review.
-
Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study.J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):711-723. doi: 10.1007/s10928-021-09765-w. Epub 2021 Jun 11. J Pharmacokinet Pharmacodyn. 2021. PMID: 34117565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials